Targeting antioxidants for cancer therapy

A Glasauer, NS Chandel - Biochemical pharmacology, 2014 - Elsevier
Cancer cells are characterized by an increase in the rate of reactive oxygen species (ROS)
production and an altered redox environment compared to normal cells. Furthermore, redox …

Aiding and abetting roles of NOX oxidases in cellular transformation

K Block, Y Gorin - Nature Reviews Cancer, 2012 - nature.com
NADPH oxidases of the NADPH oxidase (NOX) family are dedicated reactive oxygen
species-generating enzymes that broadly and specifically regulate redox-sensitive …

[HTML][HTML] Circular RNA ANAPC7 inhibits tumor growth and muscle wasting via PHLPP2–AKT–TGF-β signaling Axis in pancreatic cancer

X Shi, J Yang, M Liu, Y Zhang, Z Zhou, W Luo… - Gastroenterology, 2022 - Elsevier
Background & Aims Pancreatic cancer has the highest prevalence of cancer-associated
cachexia among all cancers. ZIP4 promotes pancreatic cancer progression by regulating …

Cell survival and metastasis regulation by Akt signaling in colorectal cancer

E Agarwal, MG Brattain, S Chowdhury - Cellular signalling, 2013 - Elsevier
Dissemination of cancer cells to distant organ sites is the leading cause of death due to
treatment failure in different types of cancer. Mehlen and Puisieux have reviewed the …

Biomarkers of response to Akt inhibitor MK-2206 in breast cancer

T Sangai, A Akcakanat, H Chen, E Tarco, Y Wu… - Clinical Cancer …, 2012 - AACR
Purpose: We tested the hypothesis that allosteric Akt inhibitor MK-2206 inhibits tumor
growth, and that PTEN/PIK3CA mutations confer MK-2206 sensitivity. Experimental Design …

The PI3K/Akt pathway in tumors of endocrine tissues

HL Robbins, A Hague - Frontiers in endocrinology, 2016 - frontiersin.org
The phosphatidylinositol 3-kinase (PI3K)/Akt pathway is a key driver in carcinogenesis.
Defects in this pathway in human cancer syndromes such as Cowden's disease and Multiple …

[PDF][PDF] MicroRNA‐331‐3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine‐rich repeat protein phosphatase

RM Chang, H Yang, F Fang, JF Xu, LY Yang - Hepatology, 2014 - Wiley Online Library
Hepatocellular carcinoma (HCC) is a highly invasive tumor with frequent intrahepatic or
pulmonary metastasis, which is the main reason for high recurrence and poor survival of …

Turning off AKT: PHLPP as a drug target

AC Newton, LC Trotman - Annual review of pharmacology and …, 2014 - annualreviews.org
Precise control of the balance between protein phosphorylation, catalyzed by protein
kinases, and protein dephosphorylation, catalyzed by protein phosphatases, is essential for …

Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases

SJ Rodgers, DT Ferguson, CA Mitchell… - Bioscience …, 2017 - portlandpress.com
Class I phosphoinositide 3-kinase (PI3K) generates phosphatidylinositol 3, 4, 5-
trisphosphate (PtdIns (3, 4, 5) P 3) at the plasma membrane in response to growth factors …

Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification

B Meeusen, V Janssens - The international journal of biochemistry & cell …, 2018 - Elsevier
Aberrant protein phosphorylation is one of the hallmarks of cancer cells, and in many cases
a prerequisite to sustain tumor development and progression. Like protein kinases, protein …